Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

Home/The Filing Wire/Aurinia Pharmaceuticals Inc/ 4

SEC Filing · 4

Aurinia Pharmaceuticals Inc

AUPHNASDAQEQUITYCurrent

SEC Filing

Filed May 20, 2026Accepted May 20, 2026, 5:05 PM EDTCIK 1600620Accession 0001837798-26-000005
View company →Permanent SEC source ↗
Share

Company context

Current securities

AUPHNASDAQ · EQUITY · Current

Recent company filings

  1. SCHEDULE 13D/A filingAug 26, 2026
  2. 144 filingAug 21, 2026
  3. Other EventsAug 19, 2026
  4. 10-Q filingAug 6, 2026
  5. Results of Operations and Financial ConditionAug 6, 2026

Document unavailable

This filing is not currently available in the archive. Read it on SEC EDGAR ↗